SearcharxivSearch

arXiv subjects

Cora Burgwinkel

Publications and source records attributed to Cora Burgwinkel.

2 recordsLinked to original sources

Adjusting for Outcome Reporting Bias in Meta-analysis: A Multiple Imputation Approach

Background: Outcome reporting bias (ORB) occurs when study outcomes are selectively reported based on their results. ORB potentially undermines the credibility and validity of meta-analyses and contributes to research waste by distorting overall treatment effects. ORB can be viewed as a missing data problem in which unreported study outcomes introduce bias. Despite the serious implications ORB poses, it remains an underrecognized issue, with only a few adjustment methods available. Methods: We propose an approach that addresses unreported study outcomes in meta-analyses through multiple imputation for univariate and multivariate meta-analysis. To assess the impact of ORB in meta-analyses, we apply our proposed methodology to real clinical data affected by ORB, and conduct a simulation study to evaluate the method's performance under a range of scenarios. Results: The proposed method provides bias-adjusted estimates under assumed selective non-reporting mechanisms. In the application to clinical data, ORB-adjusted estimates were systematically shifted towards less extreme treatment effects compared with naive analyses, highlighting the potential magnitude of ORB in practice. The simulation study shows that the extent of adjustment depends on the assumed selection mechanism and the degree of heterogeneity, with stronger selection leading to larger adjustment. Conclusions: Imputing unreported study outcomes provides a promising approach to address ORB in meta-analyses. The multivariate approach extends ORB adjustment to jointly model correlated outcomes, allowing borrowing of strength across outcomes. Overall, we propose a practical and flexible approach for evaluating the sensitivity of univariate and multivariate meta-analytic conclusions to ORB.

stat.ME

On the use of non-concurrent controls in platform trials: A scoping review

Platform trials gained popularity during the last few years as they increase flexibility compared to multi-arm trials by allowing new experimental arms entering when the trial already started. Using a shared control group in platform trials increases the trial efficiency compared to separate trials. Because of the later entry of some of the experimental treatment arms, the shared control group includes concurrent and non-concurrent control data. For a given experimental arm, non-concurrent controls refer to patients allocated to the control arm before the arm enters the trial, while concurrent controls refer to control patients that are randomised concurrently to the experimental arm. Using non-concurrent controls can result in bias in the estimate in case of time trends if the appropriate methodology is not used and the assumptions are not met. In this paper, we faced two main objectives. In the first, we aimed to identify the methods currently available for incorporating non-concurrent controls, clarify the key concepts and assumptions, and name the main characteristics of each method. For this purpose, we systematically searched research articles on methods to include non-concurrent controls. The second objective is to summarise the current regulatory view on non-concurrent controls to clarify the key concepts and current guidance. Therefore, we conducted a systematic search in regulatory guidelines regarding using non-concurrent controls and summarised the most relevant arguments and recommended methods. Finally, we discuss the advantages and potential caveats of using non-concurrent controls.

stat.ME